Cervical cancer screening in rural Bhutan with the care HPV test on self-collected samples: An ongoing cross-sectional, population-based study (REACH-Bhutan)

BMJ Open

Volumn 7, Issue 7, 2017, Pages

  Baussano, Iacopo ^a   Tshering, Sangay ^b   Choden, Tashi ^c   Lazzarato, Fulvio ^a,d,e   Tenet, Vanessa ^a   Plummer, Martyn ^a   Franceschi, Silvia ^a   Clifford, Gary M ^a   Tshomo, Ugyen ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Dewanthang Hospital   (Bhutan)

^c Royal Government of Bhutan   (Bhutan)

^d CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Bhutan; care HPV; Cervical cancer screening; rural population; self collection

Indexed keywords

ADULT; AGE; ARTICLE; BHUTAN; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHY; HEALTH CENTER; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; RURAL AREA; TRAVEL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; COMMUNITY PARTICIPATION; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PROCEDURES; REGRESSION ANALYSIS; RURAL POPULATION; SPECIMEN HANDLING; STATISTICS AND NUMERICAL DATA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; BHUTAN; COMMUNITY PARTICIPATION; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; REGRESSION ANALYSIS; RURAL POPULATION; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 85025072176     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-016309     Document Type: Article

References (24)

1. Ervik M, Lam F, Ferlay J, et al. Cancer Today Lyon, France: International Agency for Research on Cancer. 2016. http://gco. iarc. fr/today (accessed 11 November 2016).
2. Dhendup T, Tshering P. Cervical Cancer knowledge and screening behaviors among female university graduates of year 2012 attending national graduate orientation program, Bhutan. BMC Womens Health 2014;14:44.
3. Dorji T, Tshomo U, Phuntsho S, et al. Introduction of a National HPV vaccination program into Bhutan. Vaccine 2015;33:3726-30.
4. Ministry of Health. National Health Survey. Thimphu, Bhutan: Ministry of Health, 2012.
5. Baussano I, Tshomo U, Clifford GM, et al. Cervical cancer screening program in Thimphu, Bhutan: population coverage and characteristics associated with screening attendance. BMC Womens Health 2014;14:147.
6. The World Bank. Rural population. http://data. worldbank. org/indicator/SP. RUR. TOTL. ZS? locations= BT (accessed 11 January 2017).
7. Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening. Second edition-summary document. Ann Oncol 2010;21:448-58.
8. Ronco G, Dillner J, Elfstr KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524-32.
9. Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): A population-based cluster-randomised trial. Lancet Glob Health 2015;3:e85-e94.
10. Tsu V, Jerimo J. Saving the world's women from cervical Cancer. N Engl J Med 2016;374:2509-11.
11. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervicalcancer screening in developing regions: A cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-36.
12. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervicalcancer screening in developing regions: A cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-36.
13. Tuerxun G, Yukesaier A, Lu L, et al. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 methods in diagnosing cervical intraepithelial neoplasia Grade 2+ in Xinjiang Uyghur Women. Oncologist 2016;21:825-31.
14. Labani S, Asthana S. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening. J Epidemiol Community Health 2016;70:72-7.
15. Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, et al. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPVDNA assay in Ghana. Gynecol Oncol Res Pract 2017;4:5.
16. Segondy M, Kelly H, Magooa MP, et al. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. Br J Cancer 2016;115:425-30.
17. Bansil P, Lim J, Byamugisha J, et al. Performance of cervical cancer screening techniques in HIV-infected women in Uganda. J Low Genit Tract Dis 2015;19:215-9.
18. Lorenzi AT, Fregnani JH, Possati-Resende JC, et al. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas? Cancer Cytopathol 2016;124:581-8.
19. Maza M, Alfaro K, Garai J, et al. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: changing the secondary prevention paradigm in a lower middleincome country. Gynecol Oncol Rep 2017;20:58-61.
20. Tshomo U, Franceschi S, Dorji D, et al. Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis 2014;14:408.
21. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33.
22. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:2148-53.
23. Hall CS, Fottrell E, Wilkinson S, et al. Assessing the impact of mHealth interventions in low-And middle-income countries-what has been shown to work? Glob Health Action 2014;7:25606.
24. Howitt P, Darzi A, Yang GZ, et al. Technologies for global health. Lancet 2012;380:507-35.